If you need more lookups,
subscriptions start at $34 USD/month.
Vicky McGrath Location
Ireland
Vicky McGrath Work
Chief Executive @ (September 2018 - Present)
Prog Manager @ (January 2017 - January 2019)
Medical Affairs @ (January 2016 - January 2017)
Founder and Director @ Catapult Lifesciences Consultancy (January 2010 - January 2016)
Interim General Manager @ (January 2014 - January 2015)
Interim Director, Technology Transfer Office @ (January 2011 - January 2012)
Fellow (Entrepreneurship, Business and Commercialisation) @ (January 2011 - January 2012)
Co-founder and Head of Business Development @ Argutus Medical (January 2008 - January 2010)
Business Development Manager, Project Manager and Quality Systems Manager @ Biotrin International (January 2001 - January 2008)
Quality Systems Consultant @ (January 1999 - January 2001)
Quality Engineer @ (January 1997 - January 1999)
Vicky McGrath Education
Smurfit Business School, UCD
MBA
2002-2004
Boston University
MSc (Biomedical Engineering)
1994-1997
University College Dublin
B Eng (Mechanical Engineering)
1990-1994
Vicky McGrath Skills
GMP
Sales
Leadership
Start Ups
Medical Devices
Technology Transfer
Strategy
Product Launch
FDA
Product Development
Biotechnology
Customer Service
R&d
Validation
Cross Functional Team Leadership
Entrepreneurship
Business Development
Life Sciences
Product Management
Clinical Trials
Commercialization
Business Strategy
ISO 13485
Lifesciences
Management
Research and Development R&d
Research and Development
Vicky McGrath Summary
Vicky McGrath, based in Ireland, is currently a Chief Executive at Rare Diseases Ireland. Vicky McGrath brings experience from previous roles at Retina International, Roche Diagnostics UK & Ireland, Catapult Lifesciences Consultancy and Biosensia. Vicky McGrath holds a 2002 - 2004 MBA @ Smurfit Business School, UCD. With a robust skill set that includes GMP, Sales, Leadership, Start Ups, Medical Devices and more. Vicky McGrath has 2 emails on RocketReach.
Looking for a different Vicky McGrath?
Find contact details for 700 million professionals.